Autism & MAF as a Potential Immune Development Protocol
- Autism and Macrophage Stimulation
- Autism and the leaky gut
- Autism treatment strategies
- Autistic disorder and viral infections
- Common Sense About Autism Spectrum Disorders
- Debunking the lamestream view of autism
- Ethics in Autism Care
- Genome
- Gluten and Casein
- Immune dysfunction in autism
- Initial Observations of Elevated Nagalase Activity Associated with Autism and Observed Reductions from GC Protein
- Initial Observations of elevated Nagalase activity associated with Autism and observed reductions from GcMAF
- Low methylation levels associated with autism
- More on Viral Persistence in a Subgroup of Autism
- Parasites
- Starting MAF
- Toxins in the home
Cancer & MAF
- Tumor cell alpha-N-acetylgalactosaminidase activity and its involvement in GcMAF-related macrophage activation
- Deglycosylation of serum vitamin D3-binding protein leads to immunosuppression in cancer patients.
- Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer.
- Prognostic utility of serum alpha-N-acetylgalactosaminidase and immunosuppression resulted from deglycosylation of serum Gc protein in oral cancer patients.
- Immunotherapy of BALB.c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor
- Anti tumor effect of vitamin D-binding protein-derived macrophage activating factor on Ehrlich ascites tumor-bearing mice.
- Effects of vitamin D(3)-binding protein-derived macrophage activating factor (GcMAF) on angiogenesis
- Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice
- Effect of salivary gland adenocarcinoma cell-derived alpha-N-acetylgalactosaminidase on the bioactivity of macrophage activating factor
- Pancreatic carcinogenesis apoptosis and angiogenesis.
- Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor
- Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor
- Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor
- Glycosylation status of vitamin D binding protein in cancer patients
- Vitamin D binding protein-macrophage activating factor directly inhibits proliferation, migration, and uPAR expression of prostate cancer cells
- MAF is associated with the formation of chemical messenger pathways
- Effects of vitamin D-binding protein-derived macrophage-activating factor on human breast cancer cells.
- Vitamin D-binding protein-derived MAF, and prostate cancer.